Anish Patel insider trades: Enliven Therapeutics (ELVN) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Anish reports to the SEC
Open-market buys and sales
27 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 9, 2026 | ELVN | ↓ Sell | 48,300 | $27.99 | $1.4M | Indirect | Jan 13, 2026 (4d) |
| Dec 8, 2025 | ELVN | ↓ Sell | 6,663 | $21.02 | $140K | Indirect | Dec 10, 2025 (2d) |
| Nov 7, 2025 | ELVN | ↓ Sell | 6,667 | $17.40 | $116K | Indirect | Nov 12, 2025 (5d) |
| Oct 7, 2025 | ELVN | ↓ Sell | 6,667 | $20.10 | $134K | Indirect | Oct 9, 2025 (2d) |
| Sep 8, 2025 | ELVN | ↓ Sell | 6,667 | $20.24 | $135K | Indirect | Sep 10, 2025 (2d) |
| Aug 7, 2025 | ELVN | ↓ Sell | 6,667 | $18.24 | $122K | Indirect | Aug 11, 2025 (4d) |
| Jul 7, 2025 | ELVN | ↓ Sell | 6,667 | $19.79 | $132K | Indirect | Jul 9, 2025 (2d) |
| Jun 9, 2025 | ELVN | ↓ Sell | 6,667 | $20.34 | $136K | Indirect | Jun 11, 2025 (2d) |
| May 7, 2025 | ELVN | ↓ Sell | 6,667 | $18.39 | $123K | Indirect | May 9, 2025 (2d) |
| Apr 7, 2025 | ELVN | ↓ Sell | 6,667 | $18.04 | $120K | Indirect | Apr 9, 2025 (2d) |
| Mar 7, 2025 | ELVN | ↓ Sell | 6,667 | $21.44 | $143K | Indirect | Mar 11, 2025 (4d) |
| Feb 7, 2025 | ELVN | ↓ Sell | 6,667 | $21.93 | $146K | Indirect | Feb 10, 2025 (3d) |
| Jan 7, 2025 | ELVN | ↓ Sell | 21,700 | $24.18 | $525K | Direct | Jan 10, 2025 (3d) |
| Jan 7, 2025 | ELVN | ↓ Sell | 6,667 | $24.17 | $161K | Indirect | Jan 10, 2025 (3d) |
| Oct 18, 2024 | ELVN | ↓ Sell | 716 | $30.00 | $21K | Indirect | Oct 22, 2024 (4d) |
| Jul 16, 2024 | ELVN | ↓ Sell | 50,000 | $25.06 | $1.3M | Indirect | Jul 16, 2024 (0d) |
| Jun 6, 2024 | ELVN | ↓ Sell | 1,133 | $20.06 | $23K | Direct | Jun 10, 2024 (4d) |
| May 14, 2024 | ELVN | ↓ Sell | 1,107 | $25.00 | $28K | Direct | May 16, 2024 (2d) |
| May 9, 2024 | ELVN | ↓ Sell | 260 | $25.06 | $7K | Direct | May 13, 2024 (4d) |
| May 6, 2024 | ELVN | ↓ Sell | 4,875 | $22.72 | $111K | Direct | May 8, 2024 (2d) |
| Apr 11, 2024 | ELVN | ↓ Sell | 17,500 | $25.03 | $438K | Direct | Apr 15, 2024 (4d) |
| Apr 8, 2024 | ELVN | ↓ Sell | 4,875 | $18.60 | $91K | Direct | Apr 10, 2024 (2d) |
| Mar 6, 2024 | ELVN | ↓ Sell | 4,875 | $15.64 | $76K | Direct | Mar 8, 2024 (2d) |
| Feb 6, 2024 | ELVN | ↓ Sell | 4,875 | $15.11 | $74K | Direct | Feb 8, 2024 (2d) |
| Jan 22, 2024 | ELVN | ↓ Sell | 4,875 | $15.13 | $74K | Direct | Jan 24, 2024 (2d) |
| Jan 2, 2024 | ELVN | ↓ Sell | 13,540 | $15.02 | $203K | Direct | Jan 2, 2024 (0d) |
| Dec 26, 2023 | ELVN | ↓ Sell | 1,085 | $15.03 | $16K | Direct | Dec 27, 2023 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ELVN insiders
Open-market trades in the last 12 months
About Anish Patel's insider trades
Anish Patel is Chief Operating Officer at Enliven Therapeutics (ELVN). Since Dec 26, 2023, Anish has reported no open-market purchases and 27 sales worth $5.9M on SEC Form 4. In the last 12 months: 3 sales ($1.6M).
Their filings also include option exercises (6 filings), grants and awards (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ELVN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.